Greater Southern California Node of the Clinical Trials Network

临床试验网络大南加州节点

• 批准号: 10336684
• 负责人: YIH-ING HSER
• 金额: $ 11.71万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-06-01 至 2024-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10336684
• 关键词: Address; Area; Behavior Therapy; California; Cellular Phone; Clinical Research; Clinical Treatment; Clinical Trials Network; Collaborations; Concept Review; Data Science; Development; Drug abuse; Electronic Health Record; Faculty; Generations; Goals; Health; Health Care Research; Health Services Accessibility; Health care facility; Healthcare; Helping to End Addiction Long-term; Improve Access; Individual; Interdisciplinary Study; Intervention; Intervention Studies; Journals; Lead; Leadership; Mission; Modeling; Morbidity - disease rate; Multi-Institutional Clinical Trial; National Institute of Drug Abuse; New York; Pharmaceutical Preparations; Pharmacology; Pharmacotherapy; Population; Population Heterogeneity; Principal Investigator; Protocols documentation; Public Health; Research; Research Infrastructure; Research Personnel; Research Priority; Research Support; Seminal; Substance Use Disorder; System; Talents; Technology; Telemedicine; Testing; Training; Treatment Effectiveness; Treatment outcome; United States; United States National Institutes of Health; Vulnerable Populations; Work; base; clinical practice; clinical trial implementation; comorbidity; design; eHealth; health care service organization; health care settings; implementation science; implementation strategy; improved; improved outcome; innovation; innovative technologies; mHealth; meetings; mortality; opioid epidemic; opioid use disorder; overdose death; protocol development; response; rural area; rural setting; service delivery; student training; substance use treatment; treatment services; uptake

Project Summary/Abstract This application, responding to the Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047), requests an administrative supplement to the Rural Expansion of Medication Treatment for Opioid Use Disorder (Rural MOUD, CTN-0102). The main purpose of the parent project is to investigate the impact of telemedicine (TM) on MOUD access and retention for individuals with OUD in rural primary care settings. The coronavirus disease 2019 (COVID-19, or COVID for short) pandemic has forced many health care systems to rapidly implement remote care models, which is of direct relevance to this project. Building upon the existing research plan, we request an administrative supplement to conduct a thorough investigation of COVID’s impact on TM practices and access to MOUD in rural communities. In addition to characterizing changes in attitudes and perceptions regarding TM for OUD treatment, we will investigate and assess the impact of COVID over the next 2 years with regard to changes in MOUD access and services (especially TM) in rural primary care settings and in OUD patients’ use of substances (particularly opioids) and health conditions. Study specific aims include: Aim 1. To assess changes in MOUD access and services (especially TM) in rural primary care settings over the COVID pandemic, and Aim 2. To assess changes in OUD patients’ substance use (particularly opioids) and health conditions over the COVID pandemic. The supplement funding will support (1) qualitative data collection and analysis that includes focus groups and semi-structured interviews to document COVID impact from the perspective of community stakeholders, providers, and patients drawn from primary care clinics serving rural communities, and (2) quantitative data collection and analysis that includes health records for patients served by the rural primary care clinics as well as self-report from OUD patients’ participant surveys to investigate COVID impact on the use of healthcare, TM, and substances. Findings will contribute to scientific knowledge regarding COVID impact, responses, and consequences in rural communities, as well as to inform and shape future development of remote care models.

项目总结/摘要 本申请，响应关于可用性的特别利益通知（NOSI） 行政补充和紧急竞争性修订的研究2019小说 冠状病毒（NOT-DA-20-047），要求对农村扩张的行政补充， 阿片类药物使用障碍的药物治疗（农村MOUD，CTN-0102）。的主要目的 父项目是调查远程医疗（TM）对MOUD访问和保留的影响， 农村初级保健机构中的OUD患者。2019年冠状病毒病（COVID-19，或 简称COVID）大流行迫使许多医疗保健系统迅速实施远程护理 模型，这与该项目直接相关。根据现有的研究计划，我们 要求行政补充，以彻底调查COVID对TM的影响 在农村社区的实践和获得MOUD的机会。除了描述 态度和看法关于TM治疗OUD，我们将调查和评估的影响 未来2年新冠疫情在MOUD访问和服务（尤其是TM）方面的变化 农村初级保健环境和OUD患者使用药物（特别是阿片类药物）和健康 条件研究的具体目标包括：目标1。评估MOUD访问和服务的变化 （尤其是TM）在农村初级保健环境中应对新冠肺炎大流行，以及目标2。评估 OUD患者的物质使用（特别是阿片类药物）和健康状况在COVID期间的变化 流行病补充资金将支持（1）定性数据收集和分析， 包括焦点小组和半结构化访谈，以记录 社区利益相关者、提供者和来自初级保健诊所的患者的观点 服务农村社区，以及（2）定量数据收集和分析，包括健康 农村初级保健诊所服务的患者记录以及OUD患者的自我报告 参与者调查，以调查COVID对医疗保健，TM和物质使用的影响。 研究结果将有助于科学知识有关COVID的影响，反应， 农村社区的影响，以及为偏远地区的未来发展提供信息和塑造 护理模式